Halozyme Therapeutic (HALO)
52.36 x 1 65.10 x 1
Post-market by (Cboe BZX)
61.42 +0.60 (+0.99%) 04/30/25 [NASDAQ]
52.36 x 1 65.10 x 1
Post-market 59.93 -1.49 (-2.43%) 16:21 ET
for Wed, Apr 30th, 2025
Results
download Want to compare other data? Select Fields| Symbol | HALO | RVMD | JAZZ | ||
| Company | Halozyme Therapeutic | Revolution Medicines Inc | Jazz Pharma Plc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 60.97 | 40.22 | 116.05 | ||
| High | 61.80 | 41.17 | 117.57 | ||
| Low | 59.77 | 39.20 | 113.92 | ||
| Last | 61.42 | 40.38 | 116.96 | ||
| Change | +0.60 | -0.29 | +0.55 | ||
| % Change | +0.99% | -0.71% | +0.47% | ||
| Volume | 1,366,100 | 1,999,700 | 1,127,200 | ||
| 20-Day Average Volume | 1,581,000 | 2,167,035 | 1,287,105 | ||
| Previous Close | 60.82 | 40.67 | 116.41 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 59.85 | 36.12 | 108.13 | ||
| 20-Day Raw Stochastic | 76.85% | 87.65% | 66.31% | ||
| 20-Day Relative Strength | 53.67% | 57.51% | 49.91% | ||
| Weighted Alpha | +56.10 | -4.50 | +3.12 | ||
| Today's Opinion | 72% Buy | 56% Sell | 24% Sell | ||
| Previous Opinion | 72% Buy | 40% Sell | 24% Sell | ||
| Last Month's Opinion | 88% Buy | 88% Sell | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +5.15% since 04/23/25 | +7.85% since 04/23/25 | +12.26% since 04/23/25 | ||
| Low | 57.65 on 04/24/25 | 36.92 on 04/24/25 | 103.51 on 04/24/25 | ||
| High | 61.85 on 04/29/25 | 41.96 on 04/28/25 | 117.57 on 04/30/25 | ||
| 1-Month | |||||
| %Chg | -3.79% since 03/28/25 | +8.11% since 03/28/25 | -4.85% since 03/28/25 | ||
| Low | 55.71 on 04/09/25 | 29.17 on 04/07/25 | 95.49 on 04/09/25 | ||
| High | 64.17 on 04/01/25 | 41.96 on 04/28/25 | 127.87 on 04/02/25 | ||
| 3-Month | |||||
| %Chg | +8.86% since 01/30/25 | -6.25% since 01/30/25 | -6.47% since 01/30/25 | ||
| Low | 54.96 on 02/03/25 | 29.17 on 04/07/25 | 95.49 on 04/09/25 | ||
| High | 66.00 on 03/24/25 | 44.68 on 02/05/25 | 148.06 on 02/26/25 | ||
| 6-Month | |||||
| %Chg | +21.41% since 10/30/24 | -20.04% since 10/30/24 | +3.34% since 10/30/24 | ||
| Low | 42.01 on 11/18/24 | 29.17 on 04/07/25 | 95.49 on 04/09/25 | ||
| High | 66.00 on 03/24/25 | 62.40 on 11/11/24 | 148.06 on 02/26/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 7,513,276 | 7,561,081 | 7,174,580 | ||
| Shares Outstanding, K | 123,533 | 185,913 | 61,632 | ||
| Annual Sales | 1,015,320,000 | 0 | 4,068,950,000 | ||
| Annual Net Income | 444,090,000 | -600,090,000 | 560,120,000 | ||
| Last Quarter Sales | 298,010,000 | 0 | 1,088,170,000 | ||
| Last Quarter Net Income | 137,010,000 | -194,570,000 | 191,120,000 | ||
| 60-Month Beta | 1.32 | 1.37 | 0.42 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.26 on 02/18/25 | -1.12 on 02/26/25 | 6.60 on 02/25/25 | ||
| Latest Earnings Date | 05/06/25 | 05/14/25 | 05/06/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 15.45 | 0.00 | 6.20 | ||